Table 2.

Comparison analysis between patients of group A with and without insulin resistance.

	Non-IR patients (n = 31)	IR patients (n = 28)	p
WC (cm)	87.6 ± 12.8	95.4 ± 13.5	0.03
WHtR	0.60 ± 0.05	0.64 ± 0.05	0.03
BMI SD	2.1 ± 0.4	2.4 ± 0.5	0.02
SBP (mmHg)	111.4 ± 14.1	113.8 ± 12.7	0.39
DBP (mmHg)	68.2 ± 11.3	67.3 ± 9.4	0.42
IVSD (mm)	7.7 ± 1.1	7.9 ± 1.2	0.48
PWD (mm)	7.7 ± 1.3	7.8 ± 1.2	0.69
LVEDD (mm)	42.7 ± 4.6	44.34.5	0.34
LVESD (mm)	26.8 ± 3.2	27.9 ± 3	0.23
LVM-index	35.8 ± 5.8	38.5 ± 8.4	0.28
LA volume (ml)	40.8 ± 11.4	42.6 ± 11.7	0.61
LA strain (%)	40.5 ± 9.9	39.3 ± 10.8	0.54
EF (%)	67.5 ± 4.1	67.2 ± 3.2	0.74
E/A ratio	1.9 ± 0.5	1.8 ± 0.4	0.66
E′ (cm/s)	15.8 ± 2.1	14.9 ± 2.6	0.25
E/E′ ratio	6.3 ± 0.9	6.5 ± 1.1	0.28
GLS (%)	−19.5 ± 1.4	−17.8 ± 2.4	0.03
EAT (mm)	12.6 ± 2.1	13.3 ± 2.6	0.43
CIMT (mm)	4.8 ± 0.8	4.9 ± 0.7	0.59
β-index	3.1 ± 0.9	3.3 ± 0.7	0.38
PWV (m/s)	3.6 ± 0.6	3.8 ± 0.4	0.25
Augmentation index	4.4 ± 13.1	5.1 ± 15.4	0.93
AA diameter (mm)	23.4 ± 3.2	22.4 ± 2.8	0.33
AA stiffness	2.4 ± 0.4	2.7 ± 0.4	0.003

Numerical data are express as mean ± SD.

Insulin resistance was defined as a HOMA-IR > 2.5 in pre-pubertal and >4 in pubertal subjects.

IR, Insulin resistant; HOMA-IR, homeostasis model assessment of insulin resistance; WC, waist circumference; WHtR, waist-to-height ratio; BMI SD, body mass index standard deviation; SBP, systolic blood pressure; DBP, diastolic blood pressure; IVSD, interventricular septum; PWD, diastolic left ventricle posterior wall; LVEDD, end-diastolic left ventricular diameter; LVESD, end-systolic left ventricular diameter; LVM-index, left ventricle mass index; LA, left atrial; E/A ratio, early (E) and late (A) mitral peak velocities ratio; E′, early diastolic mitral annular velocities; E/E′, septal and lateral early diastolic mitral annular velocities; GLS, global longitudinal strain; CIMT, carotid intima–media thickness; PWV, pulse wave velocity; AA, ascending aorta; EAT, epicardial adipose tissue.

Bold values indicate a statistically significant p-value.